Lactic acid is a natural constituent of the body tissues, and it is formed during various types of physiological activities. However, it is also a frequent occurrence in a variety of diseases. When there is enhanced production of lactic acid and reduced clearance the clinical course becomes worse. This can have serious hemodynamic consequences and may even lead to death.

Serum lactate levels are useful for determining their mortality outcomes. The presence of a higher lactate level and the time required for serum lactate to return to a normal range are linked to an increased mortality risk. Hence, regular lactate measurement can serve as an effective therapeutic goal to minimize mortality rates in such patients. It is often associated with inadequate tissue perfusion, disturbances in carbohydrate metabolism or the use of some drugs. Decreased tissue perfusion can be the result of hypovolemia, sepsis, shock, CHF and other conditions. Disorders of metabolism of carbohydrates include diabetes, insulin resistance, and deficiency of glycogen storage diseases.

Lactic acidosis is a clinical problem for intensive care physicians and is commonly linked to shock. A study conducted in 2011 identified that severe lactic acidosis affected as much as 6% of the population conducting a multi-center, prospective analysis of 2550 patients. The analysis revealed that 83% of patients with severe lactic acidosis received vasopressor therapy. Mortality was 57% in this study and was higher especially in patients whose pH was 7.09 and presence of high lactic acid values. Lactatemia severity and time needed for the lactic acid level to return to normal were the factors that had an influence on survival.

There was also a high combined prevalence of shock and lactic acidosis with pH less than 7. 2 of the patients, admitting an overall mortality of almost 50%. No survival was recorded of severe lactic acidosis with shock when the pH went below 7. Conversely, the lactic acidosis seen in non-shock states was observed to be less fatal with mortality rates of 25% among patients with metformin-induced lactic acidosis and pH of 7.

It is defined by increased blood lactate concentration, and its presence correlates with higher mortality irrespective of the presence of shock and/or organ failure. Furthermore, in septic patients with mild or intermediate lactate levels, it can be noticed that in-hospital 30-day mortality is higher. This may result in a decline in heart contractility and a decrease in the sensitivity of blood vessels to vasopressors. However, lactic acidosis is not a direct indicator of mortality; there is no direct correlation between the two. There are two types: Type A, which has reduced oxygen supply or delivery and increased oxygen demand, and Type B, which are not hypoxic in origin but are caused by medications’ toxicity, congenital metabolic disorders, liver diseases, and malignancies.

The accumulation of lactate and impaired liver metabolism lead to the fact that the body becomes less capable of removing lactate from the bloodstream, this state is called lactateosis. These are numerous underlying complicated factors like severe convulsions, hypovolemia, hypotension, cirrhosis and hypothermia among others. In these situations, the liver could be impaired in metabolizing lactate, which in turn may lead to the accumulation of lactate and, finally, lactic acidosis.

The overall outcome is based on the etiology and quantity of the lactate level in patients. Possible increased lactate levels, especially in the situation of shock have been associated with higher mortality. Early diagnosis is useful for the management of the condition.

Lactic acidosis means sudden onset or worsening of the disease and suggests critical illness. Specifically, a detailed assessment of the patient’s medical history should be conducted to determine the initial cause of shock and the development of lactic acidosis. The prescription drugs that are being used by the patient or the toxins that the patient has been exposed to should also be looked into. The clinical manifestations of lactic acidosis depend on the etiology of the process, but they are most often seen in critically ill patients with hypovolemic, septic, or cardiogenic shock. Metabolic acidosis with an ion gap increased should be taken into consideration as one of the diagnoses. Lactic acidosis is a potentially lethal disorder, which may develop during antiretroviral therapy; therefore, obtaining patient history and data regarding antiretroviral treatment is crucially important.

Tachypnea, oliguria, mild hypotension, and impaired mental state are the hallmarks of lactic acidosis. Shock states such as septic, hypovolemic, or cardiogenic shock are frequently present. Physical investigations indicate evidence of tissue hypoperfusion, which can lead to tachypnea, altered mental state, oliguria, and severe hypotension.

Identification and treatment of the underlying cause

Hypoxia: Maintain the oxygen requirement with the help of additional oxygen or mechanical ventilation if required.

Sepsis: Treat infections with broad spectrum antibiotics and stabilize the patient’s hemodynamic status using fluids and vasopressors.

Cardiovascular Support: Stabilize any cardiac dysfunction or shock with relevant medications and proper treatment immediately.

Supportive Care

Intravenous Fluids: Give isotonic saline to enhance the tissue sources of oxygen and the renal perfusion.

Bicarbonate Therapy: It can be used only in conditions with extreme acidosis where pH is below 7.1

Hemodialysis: Most beneficial in instances where acidosis is extreme, such as in the presence of renal failure, toxins, or drugs overdose.

Oxygen Therapy

Manage elevated blood oxygen levels; if necessary, provide supplemental oxygen and assist in tissue oxygenation to lower lactate levels. This can be achieved by nasal prongs, face mask or invasive mechanical ventilation if the patient’s condition deteriorates. In situations of respiratory failure or severe hypoxemia, mechanical ventilation should be employed. Promote sufficient oxygenation and decrease the work of breathing.

Endocrinology, Metabolism

Fluid Management

Intravenous Fluids: Give isotonic saline or lactated Ringer’s solution to enhance blood flow and supply oxygen to the tissues. This may be useful in reversing the elevated lactate levels due to improved renal elimination process and restoration of volume depletion.

Correction of Hypoperfusion

Blood Pressure Support: Therefore, non-pharmacological interventions such as positioning should be used to enhance the blood pressure and perfusion such as Trendelenburg position.

Mechanical Circulatory Support: In extreme conditions, use advanced technologies, for example, intra-aortic balloon pumps or extracorporeal membrane oxygenation (ECMO) to enhance cardiac activity and tissue oxygenation.

Nutritional Support

Thiamine Supplementation: Use thiamine in cases of deficiency including chronic alcohol dependence or in malnutrition so as to prevent or treat Wernicke’s encephalopathy and decrease lactate formation.

Glucose Management: Ensure the patient receives enough nourishment, including intravenous glucose, to maintain adequate energy output and avoid further lactate build up.

Endocrinology, Metabolism

Sodium Bicarbonate: It is often used for metabolic acidosis that is associated with shock or severe condition. However, whether it should be used remains a matter of controversy.

Tromethamine (Tham): It may be particularly useful compared to sodium bicarbonate because it does not generate carbon dioxide. There is some evidence that demonstrates the effect of these changes on patient outcomes, although these results are not clear.

Endocrinology, Metabolism

Thiamine (Vitamin B-1): They are employed in the management and treatment of thiamine deficiency, which may manifest in Wernicet encephalopathy syndrome. It is also used in patients with idiopathic lactic acidosis since thiamine deficiency is one of the causes of lactic acidosis.

Endocrinology, Metabolism

Hemodialysis: It is indicated in cases of lactic acidosis proving refractory or involving renal failure, drugs or toxin induced lactic acidosis. It contributes to the elimination of localized hyperkalemia and facilitates management of acid-base disturbance. The cleansing of blood involves passing blood through a dialysis machine where waste and excess acids are removed. This procedure can effectively and quickly reduce the lactate and raise the pH level.

Continuous Renal Replacement Therapy (CRRT): It is especially beneficial for those patients who experience severe dysfunction of organs and cannot be treated with basic hemodialysis therapy. The CRRT treats the patient’s blood slowly and gently and is more consistent in handling the acid base and electrolyte disturbances.

Mechanical Ventilation: For patients with respiratory failure or severe hypoxia it is useful and necessary to provide sufficient oxygen transport and ventilation. A mechanical ventilator delivers preset breaths to the patient so that the oxygen gets delivered correctly and CO2 can be removed. This aids in the decrease of lactate formation because of enhanced oxygen supply to the tissues.

Extracorporeal Membrane Oxygenation (ECMO): It is used in the cases of irreversible pulmonary and cardiac breakdown when ordinary measures fail. This involves circulation of blood through an artificial lung or oxygenator and then returned to the circulatory system freeing up the lungs and heart to recover. This enhances and helps in the removal of lactate from the muscles thus maintaining the acid base balance of the body.

Intra-aortic Balloon Pump (IABP): It is applied in those patients who have severe cardiac dysfunction, the conditions like cardiogenic shock, it supports the increase in blood supply in the coronary arteries and gives the reduction of oxygen demands in myocardium. A balloon catheter is introduced into the aorta and inflated when the ventricles are relaxed or during diastole and this enhances the blood flow into the coronary arteries and reduces the afterload or the resistance to blood flow and hence augments the tissue perfusion.

Endocrinology, Metabolism

Immediate Management: Relies on optimizing patient status by treating conditions like hypoxia, hypoperfusion, or sepsis that may be contributing to the development of complications. This frequently includes oxygen administration, fluid replenishment, and management of any infections as well.

Specific Treatment: If the cause of the behaviour is known, then certain treatments may be required. For instance, Metformin with other drugs whose consumption is suspected to have led to the situation should be withdrawn, and the patient must be given appropriate care.

Monitoring and Supportive Care: Closely monitoring of the acid-base balance, the electrolyte levels and the status of vital organs is essential. Treatment support may encompass renal replacement therapy where the kidney functions are significantly impaired.

Prevention of Recurrence: After it has become stabilized, attempts are made to avoid the condition from recurring through disease treatment and frequent follow-ups.